LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 2,441 pages found matching data breach- Roche puts Accutane profits over Lives of Consumers
Aug-31-06 In 1985, Accutane's package insert directed at doctors first mentioned reports of depression in patients taking the acne drug, which means that more than 20 years ago, Hoffman-LaRoche at least suspected there might be a risk of depression and suicide by persons taking the drug. However, Roche's financial records show that the company is not about to let a... - Merck still fighting Vioxx lawsuits individually
Aug-30-06 Despite two major defeats, Merck, makers of the pain reliever Vioxx, plan to fight each case individually, rather than settling them all at once. It's a strange move, considering that Merck has lost some high profile cases recently. According to Paul Davies in The Wall Street Journal , some legal observers say that Merck's decision was based on the numb... - Big Pharma Bankrupting US Health Care System
Aug-29-06 ig Pharma is bankrupting the nation's health care system by convincing prescribing doctors to over-medicate patients with expensive psychiatric drugs and then send the bills to government programs like Medicaid and Medicare. The peddling of the new generation of psychiatric drugs that include the selective serotonin reuptake inhibitors antidepressants (S... - False advertising for Pantene has upset People around the World
Aug-24-06 People from around the world have been upset by false advertising claims about Pantene Pro-V shampoo. Last year, Proctor & Gamble was accused two times of falsely advertising its products in China. In the case of Pantene Pro-V, an advertising standards agency ordered the commercial be taken off the air. Additionally, the Advertising Standards Authority... - Fen-Phen May Cause Rummage Sale of Wyeth Assets - Fen-Phen Trial Resources
Aug-23-06 On August 18, 2006, Bloomberg News reported that Wyeth has faced more than 175,000 claims since fen-phen was removed from the market, and that over the past 9 years, the company has settled many claims without forcing fen-phen users to file a lawsuit. All total, the company has set aside more than $21 billion to cover legal costs and settlements since... - Lawmakers say FDA better Clean Up its Act
Aug-18-06 For six years, the Bush administration has placed pharmaceutical industry interests ahead of public interest by appointing persons with strong ties to drug companies to high level positions at the FDA. As a result, Congressional investigations and a recent survey indicate that the health and safety of all Americans is being compromised. On July 20, 200... - Edison Chouest Offshore Breach of Contract Settlement
The Port of Galveston filed a $91 million breach of contract lawsuit in February 2005 against the company. In 2000, Edison Chouest Offshore had signed a lease agreement to build a terminal on Pelican Island to support offshore energy activities. The project, dubbed C-Port Galveston, never started. The Port accused Edison Chouest of reneging on a multi... - $2 Million Fine Small Potatoes For Kaiser Transplant Disaster
Aug-13-06 Although the $2 million fine levied against Kaiser Permanente was the largest ever imposed by the California Department of Managed Health Care, it seems like small potatoes considering the damage caused by the HMO's failed kidney transplant program. The second largest fine ever levied against an HMO was $1 million back in 2002, following the death of a pa... - Merck keeps right on pushing Fosamax
Aug-11-06 New York, NY Merck's second-best selling drug, Fosamax , has been linked to jaw bone death, although sales of the drug remain steady with no decrease whatsoever. Jaw bone deth is a condition that can involve severe pain, infection, loose teeth, exposed bone, loss of function and disfigurement, according to the American Association of Oral and Maxillofa... - Lawsuits Multiply For Johnson & Johnson's Charite Spine Disc
Aug-7-06 According to the Institute of Medicine, over a million Americans are severely injured each year by medical devices. In 2002 alone, the FDA received more than 111,000 reports of adverse events involving medical devices. That number has increased since the Charite artificial spinal disc was approved for use in the US in October 2004. As of July 2006,... - Natrecor: A History of Shady Practices
Aug-6-06 It's incredulous that a drug approved for very limited use could actually be given to a wide range of people. Yet this is what happened in the case of Natrecor (nesiritide), a drug approved by the FDA for emergency use only in hospitals. Somehow, Natrecor managed to evolve from emergency-only to preventative-maintenance use, despite not receiving FDA appr... - Zyprexa Lawsuits - Eli Lilly May Lose Insurance Coverage
Aug-3-06 In the company's first quarter report for 2006, Eli Lilly says it is having problems with insurance coverage. "We have experienced difficulties in obtaining product liability insurance due to a very restrictive insurance market," the report says, "and therefore will be largely self-insured for future product liability losses." Although Lilly has cover... - Paxil Category Warning too late for my Baby
Aug-3-06 "This is what I want to say to GlaxoSmithKline, the manufacturers of Paxil: How can you let money come before people's lives and well-being and have no conscience?" In 2001, 22-year-old Nancy Jones went to a mental health clinic to seek treatment for anxiety and depression and was prescribed Paxil. Unfortunately, Jones didn't know that she was three mont... - Eli Lilly and Co. under fire for Zyprexa
Aug-1-06 On July 24, 2006, Mississippi became the fifth state to file a lawsuit against Eli Lilly and Co. for its sales and marketing of Zyprexa (olanzapine). The lawsuit was filed in Lafayette County Circuit Court. According to a special attorney general who is handling the case, the lawsuit was filed to recover money the state of Mississippi spent purchasin... - e-Plus Inc. fraud Settlement
In January 2005 GMAC Commercial sued e-Plus Inc. for about $10.65 million seeking payment of promissory notes from an alleged breach of warranties regarding an assignment of debt from ePlus, as leaser, for leases with Cyberco Holdings. The original claim totaled $13. 4 million with a trial set for July 2006. In June, Cyberco principal pled guilty to fra... - GlaxoSmithKline Sued Over Paxil Birth Defects
Jul-29-06 A lawsuit was filed against GlaxoSmithKline on July 28, 2006, in Philadelphia on behalf of Adrian Vasquez, who was born on April 19, 2004, with birth defects as a result of his mother having been prescribed Paxil during pregnancy. Paxil belongs to the class of antidepressant drugs known as selective serotonin re-uptake inhibitors (SSRIs). At birth, Ad... - Backdating of Stock Options under Federal Investigation
Jul-29-06 The U.S. Security and Exchange Commission (SEC) has announced that they will be investigating nearly 80 companies for stock option 'backdating' with nearly 40 companies facing criminal probes by the U.S. Justice Department. Federal officials held a [ press conference ] on July 21 in San Francisco to announce civil and criminal charges relating to allegati... - FDA Official Wants Ketek Support Withdrawn
Jul-26-06 At least one U.S. drug safety official wants Ketek taken off the shelves. The New York Times has reported that Dr. David Graham, a U.S. drug safety official with the Food and Drug Administration believes that the FDA's 2004 approval of the drug Ketek -- manufactured by Sanofi-Aventis for the treatment of acute upper respiratory tract diseases -- was a mistak... - CGI-AMS whistleblower fraud Settlement
Four Ohio state employees alleged false billing practices by CGI-AMS Inc., a computer consulting firm carried out in 1999. The whistleblowers said that AMS billed top dollar for work performed by unqualified employees in a $95 million contract with former Ohio Department of Human Services. In 1997, AMS was hired to install a computer system that would h... - No Medicaid for Charité Artificial Spinal Disc
Jul-22-06 On May 16 2006, Centers for Medicare and Medicaid Services (CMS) denied Medicare coverage for Charité Artificial Spinal Discs in patients 60 years or older. The Wall Street Journal reported that there was a lack of evidence to indicate that surgery to implant the device was "reasonable and necessary", not to mention the cost: Charité comes with a pri...